avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Myog
|
ENSMUSG00000026459.4 | myogenin |
Tcf12
|
ENSMUSG00000032228.10 | transcription factor 12 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tcf12 | mm10_v2_chr9_-_72111827_72111895 | 0.57 | 2.8e-04 | Click! |
Myog | mm10_v2_chr1_+_134289997_134290015 | 0.54 | 6.2e-04 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.1 | 15.3 | GO:0035702 | monocyte homeostasis(GO:0035702) |
2.6 | 12.8 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
2.4 | 7.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.9 | 16.9 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.8 | 5.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.7 | 8.7 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.7 | 5.2 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
1.7 | 5.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
1.5 | 4.6 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
1.4 | 4.3 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.3 | 3.9 | GO:0003345 | proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
1.2 | 4.9 | GO:0061743 | motor learning(GO:0061743) |
1.2 | 5.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.2 | 7.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.1 | 18.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
1.1 | 16.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.1 | 4.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.0 | 3.1 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.0 | 3.0 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
1.0 | 2.9 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.9 | 2.7 | GO:1990523 | bone regeneration(GO:1990523) |
0.9 | 4.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.9 | 3.6 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.9 | 2.7 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.9 | 6.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.9 | 3.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.8 | 2.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.8 | 3.0 | GO:0060032 | notochord regression(GO:0060032) |
0.8 | 6.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.7 | 6.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.7 | 3.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 4.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.7 | 2.0 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.7 | 5.9 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.6 | 8.3 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 1.9 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.6 | 27.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.6 | 1.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.6 | 2.4 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.6 | 1.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.6 | 1.8 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.6 | 1.8 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.5 | 0.5 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) |
0.5 | 4.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 7.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.5 | 0.5 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.5 | 1.6 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.5 | 5.3 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.5 | 5.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.5 | 5.2 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.5 | 4.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.5 | 1.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.5 | 1.5 | GO:0015866 | ADP transport(GO:0015866) |
0.5 | 2.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 1.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.5 | 1.9 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.5 | 1.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.5 | 6.0 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.4 | 2.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 2.7 | GO:0032796 | uropod organization(GO:0032796) |
0.4 | 0.4 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.4 | 1.3 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.4 | 5.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.4 | 3.9 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.4 | 12.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.4 | 0.9 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 7.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 2.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 5.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.4 | 4.2 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.4 | 1.3 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.4 | 1.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.4 | 7.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.4 | 1.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.4 | 2.0 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 1.6 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.4 | 1.6 | GO:0072185 | canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.4 | 3.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 0.8 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.4 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.1 | GO:0002270 | plasmacytoid dendritic cell activation(GO:0002270) |
0.4 | 3.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 1.1 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 1.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.4 | 0.4 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.4 | 2.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 5.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.3 | 1.4 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.3 | 3.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.7 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.3 | 2.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 1.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 4.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 3.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 0.6 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.3 | 15.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 1.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.3 | 0.9 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 1.5 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 0.6 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.3 | 1.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 4.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.3 | 0.9 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.3 | 7.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.3 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 7.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 0.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.3 | 6.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.3 | 0.8 | GO:0035826 | rubidium ion transport(GO:0035826) hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 7.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 1.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 2.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.3 | 6.9 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.3 | 1.1 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
0.3 | 6.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.3 | 0.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.3 | 2.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 1.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 1.3 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 3.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.3 | 1.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.3 | 0.3 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.2 | 1.5 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 2.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 2.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 0.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 1.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.9 | GO:0033575 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.2 | 1.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 1.9 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.9 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.2 | 0.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 1.3 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 8.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 0.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.2 | 2.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.8 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 1.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 2.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 1.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 1.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 1.0 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
0.2 | 6.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 1.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 2.1 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.2 | 0.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.2 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.9 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 1.6 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.5 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 1.7 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 0.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 0.5 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
0.2 | 1.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 1.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 1.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 1.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.2 | 0.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 0.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 0.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.1 | 0.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.1 | 4.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.9 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.8 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 1.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.4 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.6 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 1.3 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 2.6 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.8 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.7 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.4 | GO:0071462 | cellular response to mercury ion(GO:0071288) cellular response to water stimulus(GO:0071462) |
0.1 | 0.4 | GO:1904980 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.1 | 2.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.1 | 5.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.6 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 1.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.8 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 2.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 1.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.3 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.1 | 2.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 2.7 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 1.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 10.0 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 2.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.1 | 0.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 2.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 1.5 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 1.5 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 1.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 1.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 1.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 0.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.1 | 0.3 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 2.1 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 1.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 1.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 1.7 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.4 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 1.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.7 | GO:0002118 | aggressive behavior(GO:0002118) |
0.1 | 0.7 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 2.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.3 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 2.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.1 | 0.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 3.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.6 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 1.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 1.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.5 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.1 | 3.4 | GO:0048747 | muscle fiber development(GO:0048747) |
0.1 | 1.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.2 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 2.6 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 4.9 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.1 | 0.9 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.4 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.3 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.1 | 3.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 1.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.1 | 1.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.5 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.1 | 2.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 3.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.4 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 1.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 1.2 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.5 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 0.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.0 | 1.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.3 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.6 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 1.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 0.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.0 | 1.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.4 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.2 | GO:0061296 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) regulation of branch elongation involved in ureteric bud branching(GO:0072095) mesonephric duct formation(GO:0072181) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
0.0 | 0.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.0 | 0.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.4 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 1.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 1.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.0 | 0.4 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 1.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 1.4 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.4 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 1.1 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.0 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 1.3 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.5 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.2 | GO:0014856 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.9 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.0 | 0.4 | GO:0099612 | protein localization to axon(GO:0099612) |
0.0 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.8 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.6 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.3 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.0 | 1.6 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.5 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.2 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 2.1 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.0 | 0.5 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.1 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.0 | 1.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.7 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.7 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.3 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.2 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.9 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 1.6 | GO:0022408 | negative regulation of cell-cell adhesion(GO:0022408) |
0.0 | 0.6 | GO:0007568 | aging(GO:0007568) |
0.0 | 0.0 | GO:1900625 | mast cell cytokine production(GO:0032762) regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) monocyte aggregation(GO:0070487) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 1.7 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.5 | GO:0009712 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
0.0 | 0.4 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.0 | 0.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.5 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.4 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.2 | 6.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
1.7 | 5.2 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
1.5 | 7.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.2 | 28.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.1 | 4.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 15.8 | GO:0005861 | troponin complex(GO:0005861) |
0.9 | 2.6 | GO:0005940 | septin ring(GO:0005940) |
0.8 | 3.4 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.8 | 33.6 | GO:0031430 | M band(GO:0031430) |
0.8 | 8.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.7 | 2.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 6.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.6 | 2.5 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.6 | 6.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.5 | 6.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 8.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.4 | 6.4 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 11.8 | GO:0031672 | A band(GO:0031672) |
0.4 | 3.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 1.6 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 2.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 1.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.4 | 4.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 4.5 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.3 | 1.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.3 | 1.6 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 1.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 0.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.3 | 1.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 1.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.3 | 1.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 8.5 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 1.0 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.2 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 0.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 3.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 0.4 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.2 | 1.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 6.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.6 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 4.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 18.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 1.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 4.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 2.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 7.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 2.1 | GO:0005767 | secondary lysosome(GO:0005767) |
0.1 | 1.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 5.1 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 5.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.1 | 0.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 7.3 | GO:0005844 | polysome(GO:0005844) |
0.1 | 1.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.5 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 0.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.1 | 0.3 | GO:1990696 | USH2 complex(GO:1990696) |
0.1 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 5.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 10.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 2.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 5.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 1.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 3.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.4 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) RISC-loading complex(GO:0070578) |
0.0 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.5 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 2.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 1.1 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 1.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.7 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.2 | GO:1990032 | climbing fiber(GO:0044301) parallel fiber(GO:1990032) |
0.0 | 8.6 | GO:0005819 | spindle(GO:0005819) |
0.0 | 2.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 6.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 7.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 0.4 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 2.6 | GO:0005930 | axoneme(GO:0005930) |
0.0 | 0.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 1.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 2.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 3.0 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 1.8 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 2.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 3.2 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) cytosolic proteasome complex(GO:0031597) |
0.0 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 3.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 2.7 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 16.6 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.0 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 1.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 1.0 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 0.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 22.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.8 | 5.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
1.3 | 3.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.2 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.2 | 4.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.2 | 10.5 | GO:0034711 | inhibin binding(GO:0034711) |
1.1 | 11.3 | GO:0031014 | troponin T binding(GO:0031014) |
1.1 | 5.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.0 | 4.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.0 | 16.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.0 | 5.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 5.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.0 | 2.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.0 | 18.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.9 | 7.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.9 | 2.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.8 | 2.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.7 | 2.2 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.6 | 5.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 5.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.6 | 2.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.6 | 2.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.6 | 6.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.6 | 2.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 2.2 | GO:0038100 | nodal binding(GO:0038100) |
0.5 | 4.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 4.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.5 | 4.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.5 | 4.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 1.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.5 | 2.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 3.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.4 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.4 | 2.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 1.6 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.2 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.4 | 14.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.4 | 9.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 1.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 7.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 5.1 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 1.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.4 | 1.1 | GO:0000401 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.4 | 1.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.4 | 1.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 3.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 4.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 1.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.3 | 3.7 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 2.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 1.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 1.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 1.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 4.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.3 | 0.9 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.3 | 5.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 1.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 0.8 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.3 | 7.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 11.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 1.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.3 | 1.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 4.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 15.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 6.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.2 | 7.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 1.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 1.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.2 | 1.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.8 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.2 | 1.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 6.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 1.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 2.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 0.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 3.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 0.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.6 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.2 | 5.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 6.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 16.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.1 | 1.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 2.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.4 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 1.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 5.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.9 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 2.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 2.0 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 1.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 0.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.5 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
0.1 | 0.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.1 | 5.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 1.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
0.1 | 5.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 2.0 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 2.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 1.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 4.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 3.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 3.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 5.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.6 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 4.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 1.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 1.0 | GO:0016918 | retinal binding(GO:0016918) |
0.1 | 1.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 0.6 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 4.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 2.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 2.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 12.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 1.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 2.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 7.9 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.4 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 5.8 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.0 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 1.1 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.1 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.0 | 1.8 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 1.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 1.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.6 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 1.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 9.7 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 1.0 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 1.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 2.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 2.5 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 2.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.0 | 0.1 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 1.9 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.3 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.7 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 3.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 4.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 6.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 11.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 7.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 18.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 7.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 11.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 7.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 9.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 14.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 4.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 4.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 7.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 0.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 1.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 1.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 6.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 3.9 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 3.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 2.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 4.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 3.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.5 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.8 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.4 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 1.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.3 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID RHOA PATHWAY | RhoA signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 12.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.8 | 7.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 30.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.6 | 1.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.5 | 27.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.5 | 7.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 6.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.4 | 13.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 6.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.3 | 6.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.3 | 4.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.3 | 7.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 14.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 9.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 10.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 10.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 2.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 3.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 3.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 1.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 4.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 4.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 7.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 3.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.9 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 4.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 4.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 2.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 7.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 3.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 2.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 2.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.1 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 6.8 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 1.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 8.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 6.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 4.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 1.7 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 2.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.7 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 1.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |